Adverse drug reactions (ADRs) remain a common clinical problem since they can mimic many diseases and cause significant morbidity and mortality. Judicious prescribing is important to minimize ...

Generic drugs manufactured in India are linked to significantly more "severe adverse events" for patients who use them than equivalent drugs produced in the United States, a new study finds. These ...

The Pharmacovigilance Programme of India (“PvPI”) is the primary, drug safety monitoring programme in India which collects, ...

shares reached a new 52-week low on Friday after The Wall Street Journal reported widespread adverse events linked to the animal health company’s osteoarthritis pain drugs Librela and Solensia.

A new study reveals that generic drugs manufactured in India have a higher association with severe adverse events such as hospitalization, disability, and death compared to those made in the U.S ...

A new study has found that generic drugs manufactured in India are linked to significantly more severe adverse events — including hospitalization, disability and in some cases death — compared ...